II. Epidemiology
- Rare Prevalence: 4 to 5 per 1 Million Children
III. Precautions
- Exercise caution in age <3 years presenting with atypical, refractory skin lesions (often misdiagnosed initially)
IV. Pathophysiology
- Rare group of disorders with proliferation of Langerhans Cells (White Blood Cell subtype)
- Originates in the Bone Marrow from progenitor cell proliferation of myleoid Dendritic Cells
- Lesions infiltrate bones (80% of cases, esp. skull), skin, lung and in some cases the Pituitary Gland
- Most often presents in childhood, especially infancy, with atypical skin lesions mistaken for other conditions (e.g. Eczema)
- Oncogenic mutation BRAF V600E found in 64% of cases
V. Symptoms
- Fever
- Sore Oral Mucosa
- Atypical rash (see below)
VI. Findings
- Classic Triad (10%)
- Lytic bone lesions (esp. Skull defects)
- Diabetes Insipidus
- Exophthalmos
- Multisystem findings in >87% of patients with skin lesions
- Acute disseminated multisystem disease is more common in age <3 years
- Growth retardation
- Developmental Delay
- Oral Changes
- Gum swelling and necrosis
- Extrusion of teeth
- Atypical skin lesions
- Bone lesions (80% of cases)
- Skull is most often affected
- Hematologic
- Lung changes
VII. Labs
-
Complete Blood Count
- Hemoglobin or Hematocrit consistent with Anemia
- White Blood Cell Count consistent with Leukopenia
- Platelet Count consistent with Thrombocytopenia
- Chemistry panel and Serum osmolarity
- Diabetes Insipidus changes
VIII. Imaging
IX. Diagnosis
- Skin biopsy
- Bone Marrow Biopsy
X. Prognosis
- Multisystem disease
- More common in age <3 years
- Worse prognosis if involvement of liver, Bone Marrow or Spleen (five year survival 77%)
- Single organ involvement
- More common in age >3 years old
- Better prognosis with five year survival approaching 100%